Chitosan 用于 高甘油三酯血症
D 研究 目前仅存在初步研究(实验室研究、病例报告)。Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.
结论
Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.
Key Study Findings
研究人群: Rat model
研究人群: AlCl3-induced neurotoxicity rat model
Key Statistics
3
研究数量
200
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- fatbinding:
- 1,500-3,000 mg/day before meals
- cholesterolsupport:
- 1,000-3,000 mg/day
上限: Not formally established; GI side effects at higher doses
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
最佳服用时间: 15-30 minutes before meals containing dietary fat
Safety & Side Effects
已报告的副作用
- ⚠ Constipation
- ⚠ Gas and bloating
- ⚠ Nausea
- ⚠ Allergic reactions in those with shellfish allergy (contraindicated)
已知相互作用
- ● Fat-soluble vitamins (A, D, E, K — may reduce absorption)
- ● Oral medications (may bind and reduce absorption — separate by 2 hours)
- ● Warfarin (may reduce vitamin K absorption, affecting INR)
可耐受最高摄入量: Not formally established; GI side effects at higher doses
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Chitosan help with 高甘油三酯血症?
How much Chitosan should I take for 高甘油三酯血症?
Are there side effects of Chitosan?
How strong is the evidence for Chitosan and 高甘油三酯血症?
Related Evidence
Chitosan 用于其他健康状况
References
- [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
- [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
- [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。